Nurse-led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type1 diabetes when compared with routine diabetes clinic attendance

Diabetic Medicine

Volumn 28, Issue 3, 2011, Pages 373-379

  Wallymahmed, M E ^a   Morgan, C ^a   Gill, G V ^a   MacFarlane, I A ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Cardiovascular disease; Nurse led clinics; Type1 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; INSULIN; LIPID;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

ADULT; AMBULATORY CARE; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; RISK REDUCTION BEHAVIOR;

EID: 79851504308     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03224.x     Document Type: Article

References (25)

1. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16: 466-471.
2. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type1 diabetes complications. The Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006; 55: 1463-1469.
3. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type1 diabetes mellitus compared with a non-diabetic population from the UK general research database, 1992-1999. Diabetologia 2006; 49: 660-666.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with Type1 diabetes. N Engl J Med 2005; 353: 2643-2653.
6. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type1 diabetic patietns in Norway. Diabetologia 2006; 49: 298-305.
7. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al. Mortality from heart disease in a cohort of 23000 patients with insulin-treated diabetes. Diabetologia 2003; 46: 760-765.
8. European Diabetes Policy Group. A desktop guide to Type1 (insulin-dependent) diabetes mellitus. Diabet Med 1999; 16: 253-256.
9. NICE. Type1 Diabetes: National Clinical Guidance for Diagnosis and Management in Primary Care. London: National Institute for Clinical Excellence, 2004.
10. Joint British Societies. JBS2: Joint British Societies Guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91: v1-52.
11. Wallymahmed ME, Pinkney J, Saunders S, MacFarlane IA. Vascular risk factors in patients with type1 diabetes. Pract Diabetes Int 2005; 22: 81-85.
12. Wallymahmed ME, Morgan C, Gill GV, Osman-Hicks V, Chamberlain P, MacFarlane IA. Changes in cardiovascular risk factors in a type1 diabetes population: a 3.5-year study. Pract Diabetes Int 2008; 25: 223-227.
13. Saunders SA, Wallymahmed ME, Macfarlane IA. Glycaemic control in a type1 diabetes clinic for younger adults. Q J Med 2004; 97: 575-580.
14. Saunders SA, Wallymahmed M, MacFarlane IA. Improvements in glycaemic control and cardiovascular risk factors in a cohort of patient with type1 diabetes over a 5-year period. Q J Med 2009; 102: 29-34.
15. New JP, Mason JM, Freemantle N, Teasdale S, Wong L, Bruce NJ et al. Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT). Diabetes Care 2003; 26: 2250-2255.
16. Denver EA, Barnard M, Woolfson RG, Earle KA. Management of uncontrolled hypertension in a nurse-led clinic compared with conventional care for patients with type2 diabetes. Diabetes Care 2003; 26: 2256-2260.
17. Woodward A, Wallymahmed M, Wilding J, Gill G. Successful cardiovascular risk reduction in Type2 diabetes by nurse-led care using an open clinical algorithm. Diabet Med 2006; 23: 780-787.
18. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-848.
19. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G. Risk factors for coronary heart disease in type1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004; 27: 530-537.
20. Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O et al. Spectrum and prevalence of atherogenic risk factors in 27358 children, adolescents, and young people with type1 diabetes. Diabetes Care 2006; 29: 218-225.
21. Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jorgensen K. High prevalence of cardiovascular risk factors in children and adolescents with type1 diabetes: a population-based study. Diabetologia 2008; 51: 554-561.
22. Edge JA, James T, Shine B. Longitudinal screening of serum lipids in children and adolescents with Type1 diabetes in a UK clinic population. Diabet Med 2008; 25: 942-948.
23. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactoral intervention and cardiovascular disease in patients with type2 diabetes. N Engl J Med 2003; 348: 383-393.
24. Woodward A, Wallymahmed M, Wilding JP, Gill GV. Nurse-led clinics for strict hypertension control are effective long-term: a 7-year follow-up study. Diabet Med 2010; 27: 933-937.
25. Davidson MB. How our current medical care system fails people with diabetes. Diabetes Care 2009; 32: 370-372.